2-Hydroxyethyl methacrylate (2-HEMA) sensitization, a global epidemic at its peak in Spain?


Por: Gatica-Ortega, ME, Pastor-Nieto, MA, Giménez-Arnau, AM, Mercader-García, P, Sanz-Sánchez, T, Carrascosa-Carrillo, JM, Córdoba-Guijarro, S, Sánchez-Pérez, J, Silvestre, JF, Frutos, FJOD, Tous-Romero, F, Fernández-Redondo, V, Serra-Baldrich, E, Ruíz-González, I, Pérez, RG, Miquel-Miquel, J, Guillén, PSP, Hervella-García, M, Heras-Mendaza, F, Gómez-de-la-Fuente, E, Zaragoza-Ninet, V, Gilo, AS, Rodríguez-Serna, M, Melé-Ninot, G, Descalzo, MA, de-Vega, M, García-Doval, I, Borrego, L

Publicada: 1 may 2024 Ahead of Print: 1 feb 2024
Resumen:
Background: A global epidemic of allergic contact dermatitis to (meth)acrylates has been described in relation to the widespread use of manicure products. Objectives: To evaluate the frequency of sensitization to 2-hydroxyethyl methacrylate (2-HEMA) among consecutively patch tested patients with eczema in Spain; the percentage of current relevance; the MOAHLFA index; and, the potential sources of exposure to (meth)acrylates. Methods: From January 2019 to December 2022, 2-HEMA 2% pet. was prospectively patch tested in 24 REIDAC (Spanish Allergic Contact Dermatitis Registry) centres. ResultsSix thousand one hundred thirty-four patients were consecutively patch tested with 2-HEMA 2% pet. 265/6134 (4.3%) were positive. Positive reactions of current relevance were identified to involve 184/265 (69%). The efficiency (number of patch tests needed to detect relevant positive patch test reactions) was 34 (6134/184). The variable 'occupational' was found to be significantly associated with a higher risk for relevant positive reactions to 2-HEMA (OR: 10.9; 95% CI: 8.1-14.9). Conclusion: (Meth)acrylate sensitization is a prevalent health issue in Spain. 2-HEMA 2% pet. has been identified to be a highly effective (meth)acrylate allergy marker in the GEIDAC baseline series. The responsible authorities should implement policies guaranteeing accurate labelling of industrial, medical, and consumer materials while ensuring the enforcement of said labelling through appropriate legal means.

Filiaciones:
Gatica-Ortega, ME:
 Complejo Hosp Univ Toledo, Dermatol Dept, Toledo, Spain

 Univ Castilla La Mancha, Escuela Int Doctorado, Toledo, Spain

 Acad Espanola Dermatol & Venereol, Unidad Invest, Ferraz 100,1 Izda, Madrid 28008, Spain

Pastor-Nieto, MA:
 Univ Castilla La Mancha, Escuela Int Doctorado, Toledo, Spain

 Hosp Univ Guadalajara, Dermatol Dept, Guadalajara, Spain

 Hosp Univ Fdn Jimenez Diaz, Dermatol Dept, Madrid, Spain

 Univ Alcala, Fac Med & Hlth Sci, Dept Med & Med Specialties, Alcala De Henares, Spain

Giménez-Arnau, AM:
 Univ Pompeu Fabra, Hosp Mar Res Inst, Dept Dermatol, Barcelona, Spain

Mercader-García, P:
 Hosp Gen Univ Jose Ma Morales Meseguer, Dept Dermatol, Murcia, Spain

Sanz-Sánchez, T:
 Hosp Univ Infanta Sofia, Dermatol Dept, Madrid, Spain

Carrascosa-Carrillo, JM:
 UAB, Dermatol Dept, IGTP, Hosp Univ Germans Trias & Pujol, Barcelona, Spain

Córdoba-Guijarro, S:
 Hosp Univ Fuenlabrada, Dermatol Dept, Madrid, Spain

Sánchez-Pérez, J:
 Hosp Univ La Princesa, Dermatol Dept, Madrid, Spain

Silvestre, JF:
 Hosp Gen Univ Dr Balmis, Dept Dermatol, ISABIAL, Alicante, Spain

Frutos, FJOD:
 Hosp Univ 12 Octubre, Dermatol Dept, Madrid, Spain

Tous-Romero, F:
 Hosp Univ 12 Octubre, Dermatol Dept, Madrid, Spain

Fernández-Redondo, V:
 Complejo Hosp Univ, Dermatol Dept, Santiago De Compostela, Spain

Serra-Baldrich, E:
 Hosp La Santa Creu i St Pau, Dermatol Dept, Barcelona, Spain

Ruíz-González, I:
 Complejo Asistencial Univ Leon, Dermatol Dept, Leon, Spain

Pérez, RG:
 Hosp Univ Araba, Dermatol Dept, Vitoria, Spain

Miquel-Miquel, J:
 Hosp Arnau Vilanova, Dermatol Dept, Valencia, Spain

Guillén, PSP:
 Hosp Univ Virgen Arrixaca, Dermatol Dept, Murcia, Spain

Hervella-García, M:
 Complejo Hosp Navarra, Dermatol Dept, Pamplona, Spain

Heras-Mendaza, F:
 Hosp Univ Fdn Jimenez Diaz, Dermatol Dept, Madrid, Spain

Gómez-de-la-Fuente, E:
 Hosp Univ Fdn Alcorcon, Dept Dermatol, Madrid, Spain

Zaragoza-Ninet, V:
 Hosp Gen Univ Valencia, Dept Dermatol, Valencia, Spain

Gilo, AS:
 Hosp Univ Rey Juan Carlos, Dept Dermatol, Madrid, Spain

Rodríguez-Serna, M:
 Hosp Univ La Fe, Dermatol Dept, Valencia, Spain

Melé-Ninot, G:
 Hosp Univ Sagrat Cor, Dept Dermatol, Grp Quironsalud, Barcelona, Spain

Descalzo, MA:
 Spanish Acad Dermatol, Unidad Invest Fdn Piel Sana AEDV, Madrid, Spain

de-Vega, M:
 Spanish Acad Dermatol, Unidad Invest Fdn Piel Sana AEDV, Madrid, Spain

García-Doval, I:
 Spanish Acad Dermatol, Unidad Invest Fdn Piel Sana AEDV, Madrid, Spain

Borrego, L:
 Univ Las Palmas Gran Canaria, Dept Dermatol, Hosp Univ Insular de Gran Canaria, Las Palmas Gran Canaria, Spain
ISSN: 01051873





CONTACT DERMATITIS
Editorial
WILEY, 111 RIVER ST, HOBOKEN 07030-5774, NJ USA, Dinamarca
Tipo de documento: Article
Volumen: 90 Número: 5
Páginas: 507-513
WOS Id: 001161426400001
ID de PubMed: 38351475
imagen Green Published

MÉTRICAS